Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR) Trial

NCT04190433 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04190433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04190433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR) Trial
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Withdrawn
Start date
September 1, 2020
Completion date
April 18, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, hematopoietic and lymphoid cell neoplasm, lymphoma, sarcoma